SCHEMBL45172

SCHEMBL45172

C=C[CH]NCC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7827498 0.72
SCHEMBL29620 0.72
SCHEMBL10815520 0.71
Hydrochloric Acid SCHEMBL2702442 0.69
SCHEMBL5533354 0.69
SCHEMBL5992718 0.69
SCHEMBL9600 0.67
SCHEMBL6206068 0.67
SCHEMBL44721 0.67
SCHEMBL1567546 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3683 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117999261-A Novel compounds and their use in the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-05-07 CN claimed
WO-2024061755-A1 AMINO- AND SILOXANE-FUNCTIONALIZED POLYMERS ARLANXEO DEUTSCHLAND GMBH (DE) 2024-03-28 WO claimed
US-11926957-B2 Fiber products with a coating formed from aqueous polymer dispersions CHT Germany GmbH (DE) 2024-03-12 US claimed
US-20240016810-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS YUMANITY THERAPEUTICS, INC. 2024-01-18 US claimed
US-11834447-B2 Indole derivatives and use thereof PURDUE PHARMA L.P. (US) 2023-12-05 US claimed
US-11787813-B2 Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors KSQ Therapeutics, Inc. (US) 2023-10-17 US claimed
US-11787906-B2 Biodegradable drug-polymer conjugate POLYACTIVA PTY LTD (AU) 2023-10-17 US claimed
WO-2023196955-A1 THERAPEUTIC COMBINATIONS COMPRISING UBIQUITIN- SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS AND CHEMOTHERAPY AGENTS KSQ Therapeutics, Inc. (US) 2023-10-12 WO claimed
WO-2023163227-A1 ANTIBODY-DRUG CONJUGATE UBE株式会社 2023-08-31 WO claimed
WO-2023163234-A1 ANTIBODY-DRUG CONJUGATE PRECURSOR AND INTERMEDIATE FOR SYNTHESIS THEREOF UBE株式会社 2023-08-31 WO claimed
CN-87100878-A Pyridazinone derivative and preparation thereof and kill insect, kill mite, nematicide, Fungicidal formulations 1987-09-23 CN claimed
EP-0230266-A2 Functionalized peptidyl aminodiols and -triols ABBOTT LABORATORIES (US) 1987-07-29 EP claimed
EP-0227818-A1 ANTIGLAUCOMA COMPOSITIONS. SCHERING CORP (US) 1987-07-08 EP claimed
WO-1987000055-A1 ANTIGLAUCOMA COMPOSITIONS SCHERING CORPORATION (US) 1987-01-15 WO claimed
EP-0155623-A2 Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition MERCK & CO. INC. (US) 1985-09-25 EP claimed
EP-0100053-A1 Compounds having angiotensin converting enzyme inhibitory activity and diuretic activity RORER INTERNATIONAL (OVERSEAS) INC. (US) 1984-02-08 EP claimed
US-4376830-A Sulfur cement-aggregate-organosilane compositions and methods for preparing CHEVRON RESEARCH COMPANY (US) 1983-03-15 US claimed
US-4336155-A CYANOSTYRYL COMPOUNDS AND OTHER BRIGHTENER HOECHST AKTIENGESELLSCHAFT (DE) 1982-06-22 US claimed
US-4169810-A BENZOXAZOLYLSTILBENE, BENZOTHIAZOLYLSTILBENE HOECHST AKTIENGESELLSCHAFT (DE) 1979-10-02 US claimed
US-4009297-A Gold deposition procedures and substrates upon which gold has been deposited AMP INCORPORATED (US) 1977-02-22 US claimed